ACHA4
MOLECULAR TARGETNeuronal acetylcholine receptor subunit alpha-4
ACHA4 (Neuronal acetylcholine receptor subunit alpha-4) is targeted by 50 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting ACHA4
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
About ACHA4 as a Drug Target
ACHA4 (Neuronal acetylcholine receptor subunit alpha-4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 50 compounds with documented ACHA4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
ACHA4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.